about
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Tr...
Read More
0.89
0.01
(1.14%)
37,570.7
XNAS Volume
XNAS 17 Jul, 2026 11:06 AM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
RenovoRx Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..